Persistent hepatitis C virus replication and T cell immunity in pregnancy

妊娠期丙型肝炎病毒持续复制和 T 细胞免疫

基本信息

项目摘要

DESCRIPTION (provided by applicant): Chronic hepatitis C virus (HCV) infection is characterized by stable lifelong viremia and a substantially increased risk of serious progressive liver disease. HCV persists in part because T cell immunity fails. Studies in adults have shown that cytotoxic CD8+ T cells are functionally exhausted or target viral epitopes that have mutated to escape recognition. Loss of CD4+ T helper cell activity is a hallmark of chronic hepatitis C but mechanisms that silence this critical immune response have not been identified. Chronic HCV infection appears to be modified by pregnancy. Viremia increases during pregnancy and then decreases, often by several logs, after childbirth. Our central hypothesis is that cellular immunit to HCV is fully restored, at least transiently, in the postpartum period. Two Specific Aims are proposed. Specific Aim 1 is to compare HCV-specific cellular immunity and underlying immunoregulatory changes in women with and without a substantial drop in viremia in the postpartum period. Specifically we will test the hypothesis that viral control after childbirth is associated with a shift of CD4+ and CD8+ T-cells from an exhausted to an effector state, with acquisition of multiple effector functions, susceptibility to signals from survival cytokines, and decreased predisposition to apoptosis. Further, we anticipate that declining viremia after delivery will be associated with changes in plasma cytokines and other pregnancy-related immunoregulatory molecules that promote Th1/Tc1 immunity. Specific Aim 2 is to determine the influence of pregnancy and delivery on evolution of HCV genomes and T-cell repertoire. We predict that CD8+ T cell immunity is relaxed during pregnancy, so that escape mutations in some class I epitopes revert to a sequence that is more fit for HCV replication. Postpartum resurgence of CD8+ T-cell immunity is expected to cause emergence (or re-emergence) of escape mutations in class I epitopes and include new T-cell clonotypes. Spontaneous recovery of T cell immunity that restricts HCV replication would represent a significant departure from the typical pattern of chronic infection described in men and non-pregnant women. We believe that understanding the mechanism(s) of spontaneous HCV control after childbirth is relevant to human health. For instance, it would provide insight into strategies to cure infection during a unique window of low virus replication in the mothers. The studies should also provide information on the relationship between replicative fitness and patterns of escape mutation in viruses that emerge late in pregnancy and are potentially transmissible to HLA semi-matched infants. More generally, the studies should provide a substantially new direction for unraveling the molecular basis of T cell dysfunction and approaches to immunomodulation in chronic hepatitis C and other chronic viral infections. PUBLIC HEALTH RELEVANCE: This project has relevance to public health because an estimated 1.1% of non-incarcerated women in the United States are infected with HCV. The rate is 20-40 times higher in homeless and imprisoned women. Because many HCV-infected women are of childbearing age, an understanding of virus replication and immunity in pregnancy could have important implications for the pathogenesis and therapy of this chronic infection.
描述(由申请人提供):慢性丙型肝炎病毒(HCV)感染的特征是稳定的终身病毒血症和严重进行性肝病的风险大幅增加。HCV持续存在的部分原因是T细胞免疫失败。对成人的研究表明,细胞毒性CD 8 + T细胞在功能上已经耗尽,或者靶向已经突变以逃避识别的病毒表位。CD 4 + T辅助细胞活性的丧失是慢性丙型肝炎的标志, 抑制这种关键免疫反应的机制尚未确定。慢性丙型肝炎病毒感染似乎是修改怀孕。病毒血症在怀孕期间增加,然后在分娩后减少,通常减少几个log。我们的中心假设是,细胞免疫HCV是完全恢复,至少是短暂的,在产后期间。提出了两个具体目标。具体目标1是比较HCV特异性细胞免疫和潜在的免疫调节变化的妇女和没有大幅下降的病毒血症在产后期间。具体来说,我们将测试的假设,即分娩后的病毒控制与转移的CD 4+和CD 8 + T细胞从一个疲惫的效应状态,收购多个效应功能,易感性的信号从生存细胞因子,并减少倾向于凋亡。此外,我们预计,分娩后病毒血症的下降将与血浆细胞因子和其他妊娠相关的免疫调节分子,促进Th 1/Tc 1免疫的变化。具体目标2是确定妊娠和分娩对HCV基因组和T细胞库演变的影响。我们预测,CD 8 + T细胞免疫在怀孕期间是放松的,所以在一些I类表位的逃逸突变恢复到一个更适合HCV复制的序列。产后CD 8 + T细胞免疫的复苏预计会导致I类表位中逃逸突变的出现(或重新出现),并包括新的T细胞克隆型。限制HCV复制的T细胞免疫的自发恢复将代表与在男性和非妊娠女性中描述的慢性感染的典型模式的显著偏离。我们认为,了解分娩后HCV自发控制的机制与人类健康有关。例如,它将为在母亲体内病毒复制较低的独特窗口期间治愈感染的策略提供见解。这些研究还应提供关于复制适应性与病毒逃逸突变模式之间关系的信息,这些病毒在妊娠后期出现,并可能传播给HLA半匹配的婴儿。更一般地说,这些研究应该为解开T细胞功能障碍的分子基础和慢性丙型肝炎和其他慢性病毒感染的免疫调节方法提供一个实质性的新方向。 公共卫生相关性:该项目与公共卫生有关,因为估计美国1.1%的非监禁妇女感染了HCV。无家可归和被监禁的妇女的死亡率要高出20-40倍。由于许多HCV感染的妇女是育龄妇女,了解病毒复制和免疫在怀孕期间可能有重要意义的发病机制和治疗这种慢性感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher M. Walker其他文献

Primary chimpanzee skin fibroblast cells are fully permissive for human cytomegalovirus replication.
原代黑猩猩皮肤成纤维细胞完全允许人类巨细胞病毒复制。
  • DOI:
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Karen Perot;Christopher M. Walker;R. Spaete
  • 通讯作者:
    R. Spaete
Adaptive immune responses in acute and chronic hepatitis C virus infection
急性和慢性丙型肝炎病毒感染中的适应性免疫反应
  • DOI:
    10.1038/nature04079
  • 发表时间:
    2005-08-17
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    David G. Bowen;Christopher M. Walker
  • 通讯作者:
    Christopher M. Walker
Incidental posterior rib hyperostosis on chest CT: incidence and etiology
  • DOI:
    10.1007/s00256-021-03933-2
  • 发表时间:
    2021-10-18
  • 期刊:
  • 影响因子:
    2.200
  • 作者:
    Luke Frager;Dennis Heaton;Christopher M. Walker;Kate Young;Brian M. Everist
  • 通讯作者:
    Brian M. Everist
An epitope in the V1 domain of the simian immunodeficiency virus (SIV) gp120 protein is recognized by CD8+ cytotoxic T lymphocytes from an SIV-infected rhesus macaque
猿猴免疫缺陷病毒 (SIV) gp120 蛋白 V1 结构域中的表位被感染 SIV 的恒河猴的 CD8 细胞毒性 T 淋巴细胞识别
  • DOI:
    10.1128/jvi.68.4.2756-2759.1994
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    A. Erickson;Christopher M. Walker
  • 通讯作者:
    Christopher M. Walker
Transition From Peer Review to Peer Learning: Lessons Learned
  • DOI:
    10.1067/j.cpradiol.2023.03.003
  • 发表时间:
    2023-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Elizabeth H. Parrott;Sirus Saeedipour;Christopher M. Walker;Shaun R. Best;Nick R. Harn;Ryan M. Ash
  • 通讯作者:
    Ryan M. Ash

Christopher M. Walker的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher M. Walker', 18)}}的其他基金

Strategies to enhance vaccine-primed T cell immunity against HCV
增强针对 HCV 的疫苗引发 T 细胞免疫的策略
  • 批准号:
    10797241
  • 财政年份:
    2021
  • 资助金额:
    $ 24.24万
  • 项目类别:
Strategies to enhance vaccine-primed T cell immunity against HCV
增强针对 HCV 的疫苗引发 T 细胞免疫的策略
  • 批准号:
    10205550
  • 财政年份:
    2021
  • 资助金额:
    $ 24.24万
  • 项目类别:
Strategies to enhance vaccine-primed T cell immunity against HCV
增强针对 HCV 的疫苗引发 T 细胞免疫的策略
  • 批准号:
    10409761
  • 财政年份:
    2021
  • 资助金额:
    $ 24.24万
  • 项目类别:
T Cell Immunity and HCV Infection Outcome
T 细胞免疫和 HCV 感染结果
  • 批准号:
    9346587
  • 财政年份:
    2016
  • 资助金额:
    $ 24.24万
  • 项目类别:
T Cell Immunity and HCV Infection Outcome
T 细胞免疫和 HCV 感染结果
  • 批准号:
    10000824
  • 财政年份:
    2016
  • 资助金额:
    $ 24.24万
  • 项目类别:
T Cell Immunity and HCV Infection Outcome
T 细胞免疫和 HCV 感染结果
  • 批准号:
    9325247
  • 财政年份:
    2016
  • 资助金额:
    $ 24.24万
  • 项目类别:
T Cell Immunity and HCV Infection Outcome
T 细胞免疫和 HCV 感染结果
  • 批准号:
    9759758
  • 财政年份:
    2016
  • 资助金额:
    $ 24.24万
  • 项目类别:
Persistent hepatitis C virus replication and T cell immunity in pregnancy
妊娠期丙型肝炎病毒持续复制和 T 细胞免疫
  • 批准号:
    8604366
  • 财政年份:
    2012
  • 资助金额:
    $ 24.24万
  • 项目类别:
Persistent hepatitis C virus replication and immunity in pregnancy
妊娠期丙型肝炎病毒的持续复制和免疫力
  • 批准号:
    10413150
  • 财政年份:
    2012
  • 资助金额:
    $ 24.24万
  • 项目类别:
Persistent hepatitis C virus replication and T cell immunity in pregnancy
妊娠期丙型肝炎病毒持续复制和 T 细胞免疫
  • 批准号:
    8416956
  • 财政年份:
    2012
  • 资助金额:
    $ 24.24万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10596657
  • 财政年份:
    2021
  • 资助金额:
    $ 24.24万
  • 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
  • 批准号:
    10417219
  • 财政年份:
    2021
  • 资助金额:
    $ 24.24万
  • 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 24.24万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
  • 批准号:
    nhmrc : 1059331
  • 财政年份:
    2014
  • 资助金额:
    $ 24.24万
  • 项目类别:
    Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 24.24万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
  • 批准号:
    441952-2013
  • 财政年份:
    2013
  • 资助金额:
    $ 24.24万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
  • 批准号:
    251802
  • 财政年份:
    2012
  • 资助金额:
    $ 24.24万
  • 项目类别:
    Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
  • 批准号:
    191299
  • 财政年份:
    2009
  • 资助金额:
    $ 24.24万
  • 项目类别:
    Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    8075522
  • 财政年份:
    2009
  • 资助金额:
    $ 24.24万
  • 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
  • 批准号:
    7676912
  • 财政年份:
    2009
  • 资助金额:
    $ 24.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了